CLINICAL_TRIALS
trial_result
· 2010-12-02
Clinical Trial Update: A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. [Phase 3]
Summary
A Phase 3 randomized pediatric glaucoma trial completed with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Glaucoma | Phase 3 | Status: COMPLETED | Results posted: 2010-12-02